The vaccine used in this trial, known as AHEAD-MERIT (BNT113-01), will help the immune system recognise and kill cancer cells ...

There are more than 200 types of cancers out of which breast cancer lung cancer and cervical cancer are commonly known in ...

Cancer is a debilitating illness that remains a persistent threat to humanity and is one of the leading causes of death ...

NHS England's collaboration with BioNTech is crucial in discovering individuals who may benefit from the trial.

People with head and neck cancer in England will be fast-tracked on to a clinical trial for a “potentially transformative” ...

The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer ...

University of Oklahoma researchers are conducting a first-of-its-kind study to determine whether cannabis use affects ...

This is the third cancer vaccine trial to be run through the NHS Cancer Vaccine Launch Pad, coordinated by the Southampton ...

There are several types of cancers, and one that not a lot of people know about is head and neck cancer. As opposed to the ...

Discover PDS Biotechnology's Q2 2025 progress on groundbreaking cancer trials, including VERSATILE-003. Explore durable outcomes and market growth potential.

Eftilagimod alfa shows promise as a novel immunotherapy for head and neck cancer patients with low PD-L1 expression, offering ...